O	0	10	Randomized
O	11	21	Controlled
O	22	27	Trial
O	28	30	to
O	31	37	Reduce
B-condition	38	47	Bacterial
I-condition	48	60	Colonization
I-condition	61	63	of
I-condition	64	72	Surgical
I-condition	73	79	Drains
O	80	84	with
O	85	88	the
O	89	92	Use
O	93	95	of
B-intervention	96	109	Chlorhexidine
I-intervention	109	110	-
I-intervention	110	116	Coated
I-intervention	117	126	Dressings
O	127	132	After
O	133	139	Breast
O	140	146	Cancer
O	147	154	Surgery
O	154	155	.

O	156	162	Breast
O	163	170	surgery
O	171	173	is
O	174	184	considered
O	185	186	a
O	187	192	clean
O	193	200	surgery
O	200	201	.

O	202	209	However
O	209	210	,
O	211	219	surgical
O	219	220	-
O	220	224	site
O	225	234	infection
O	235	236	(
O	236	239	SSI
O	239	240	)
O	241	246	rates
O	247	250	are
O	251	260	currently
O	261	267	higher
O	268	272	than
O	273	282	predicted
O	282	283	.

O	284	297	Postoperative
O	298	304	drains
O	305	311	remain
O	312	314	in
O	315	319	situ
O	320	323	for
O	324	331	several
O	332	336	days
O	336	337	,
O	338	342	with
O	343	353	inevitable
O	354	363	bacterial
O	364	376	colonization
O	377	380	and
O	381	390	increased
O	391	394	SSI
O	395	399	risk
O	399	400	.

O	401	405	This
O	406	416	randomized
O	417	427	controlled
O	428	433	trial
O	434	438	from
O	439	446	October
O	447	451	2016
O	452	454	to
O	455	462	January
O	463	467	2018
O	468	476	analyzed
B-eligibility	477	485	patients
I-eligibility	486	496	undergoing
I-eligibility	497	503	breast
I-eligibility	504	510	cancer
I-eligibility	511	518	surgery
O	518	519	.

O	520	523	The
O	524	532	patients
O	533	537	were
O	538	548	randomized
O	549	551	to
O	552	558	either
O	559	562	the
B-control	563	571	standard
I-control	572	577	drain
I-control	578	582	care
I-control	583	588	group
O	589	591	or
O	592	595	the
O	596	606	antiseptic
O	607	615	dressing
O	616	621	group
O	622	623	(
O	623	625	3M
O	625	626	®
O	627	635	Tegaderm
O	635	636	®
O	637	640	CHG
O	640	641	)
O	641	642	.

O	643	648	Drain
O	649	656	samples
O	657	662	taken
O	663	665	on
O	666	679	postoperative
O	680	684	days
O	685	686	(
O	686	690	PODs
O	690	691	)
O	692	693	7
O	694	697	and
O	698	700	14
O	701	705	were
O	706	714	cultured
O	715	717	as
O	718	730	standardized
O	731	733	in
O	734	737	the
O	738	748	laboratory
O	748	749	.

O	750	762	Colonization
O	763	768	rates
O	769	772	and
O	773	776	SSI
O	777	781	were
O	782	790	compared
O	791	798	between
O	799	802	the
O	803	806	two
O	807	813	groups
O	813	814	.

O	815	818	The
O	819	824	study
O	825	833	enrolled
B-total-participants	834	837	104
O	838	846	patients
O	847	851	with
O	852	855	167
O	856	864	surgical
O	865	871	drains
O	871	872	.

O	873	876	The
O	877	885	patients
O	885	886	'
O	887	895	clinical
O	896	911	characteristics
O	912	916	were
O	917	924	similar
O	925	927	in
O	928	931	the
O	932	935	two
O	936	942	groups
O	942	943	,
O	944	948	with
O	949	951	no
O	952	965	statistically
O	966	977	significant
O	978	989	differences
O	989	990	.

B-outcome	991	995	Bulb
I-outcome	996	1001	fluid
I-outcome	1002	1010	cultures
I-outcome	1011	1013	at
I-outcome	1014	1027	postoperative
I-outcome	1028	1032	week
O	1033	1034	(
O	1034	1037	POW
O	1037	1038	)
O	1039	1040	1
O	1041	1045	were
O	1046	1054	positive
O	1055	1058	for
B-cv-bin-percent	1059	1061	42
I-cv-bin-percent	1061	1062	.
I-cv-bin-percent	1062	1063	9
I-cv-bin-percent	1063	1064	%
O	1065	1067	of
O	1068	1071	the
O	1072	1079	control
O	1080	1085	group
O	1086	1089	and
B-iv-bin-percent	1090	1092	28
I-iv-bin-percent	1092	1093	.
I-iv-bin-percent	1093	1094	9
I-iv-bin-percent	1094	1095	%
O	1096	1098	of
O	1099	1102	the
O	1103	1113	antiseptic
O	1114	1119	group
O	1120	1121	(
O	1121	1122	p
O	1123	1124	=
O	1125	1126	0
O	1126	1127	.
O	1127	1129	06
O	1129	1130	)
O	1130	1131	.

B-outcome	1132	1140	Cultures
I-outcome	1141	1145	from
I-outcome	1146	1149	the
I-outcome	1150	1153	POW
I-outcome	1154	1155	2
O	1156	1166	assessment
O	1167	1171	were
O	1172	1180	positive
O	1181	1184	for
B-cv-bin-percent	1185	1187	79
I-cv-bin-percent	1187	1188	.
I-cv-bin-percent	1188	1189	7
I-cv-bin-percent	1189	1190	%
O	1191	1193	of
O	1194	1197	the
O	1198	1205	control
O	1206	1211	group
O	1212	1218	versus
B-iv-bin-percent	1219	1221	54
I-iv-bin-percent	1221	1222	.
I-iv-bin-percent	1222	1223	9
I-iv-bin-percent	1223	1224	%
O	1225	1227	of
O	1228	1231	the
O	1232	1242	antiseptic
O	1243	1248	group
O	1249	1250	(
O	1250	1251	p
O	1252	1253	=
O	1254	1255	0
O	1255	1256	.
O	1256	1259	001
O	1259	1260	)
O	1260	1261	.

B-outcome	1262	1270	Cultures
I-outcome	1271	1275	from
I-outcome	1276	1281	drain
I-outcome	1282	1287	tubes
O	1288	1292	were
O	1293	1301	positive
O	1302	1305	for
B-cv-bin-percent	1306	1308	79
I-cv-bin-percent	1308	1309	.
I-cv-bin-percent	1309	1310	8
I-cv-bin-percent	1310	1311	%
O	1312	1314	of
O	1315	1318	the
O	1319	1326	control
O	1327	1332	group
O	1333	1336	and
B-iv-bin-percent	1337	1339	50
I-iv-bin-percent	1339	1340	.
I-iv-bin-percent	1340	1341	7
I-iv-bin-percent	1341	1342	%
O	1343	1345	of
O	1346	1349	the
O	1350	1360	antiseptic
O	1361	1366	group
O	1367	1368	(
O	1368	1369	p
O	1370	1371	=
O	1372	1373	<
O	1374	1375	0
O	1375	1376	.
O	1376	1379	001
O	1379	1380	)
O	1380	1381	.

O	1382	1384	In
O	1385	1387	11
O	1388	1396	patients
O	1396	1397	,
O	1398	1400	an
B-outcome	1401	1404	SSI
I-outcome	1405	1414	developed
O	1414	1415	,
B-iv-bin-abs	1416	1417	3
O	1418	1419	(
B-iv-bin-percent	1419	1420	5
I-iv-bin-percent	1420	1421	.
I-iv-bin-percent	1421	1422	8
I-iv-bin-percent	1422	1423	%
O	1423	1424	)
O	1425	1429	from
O	1430	1433	the
O	1434	1446	intervention
O	1447	1450	and
B-cv-bin-abs	1451	1452	8
O	1453	1454	(
B-cv-bin-percent	1454	1456	15
I-cv-bin-percent	1456	1457	.
I-cv-bin-percent	1457	1458	4
I-cv-bin-percent	1458	1459	%
O	1459	1460	)
O	1461	1465	from
O	1466	1469	the
O	1470	1477	control
O	1478	1487	procedure
O	1488	1489	(
O	1489	1490	p
O	1491	1492	=
O	1493	1494	0
O	1494	1495	.
O	1495	1497	11
O	1497	1498	)
O	1498	1499	.

O	1500	1503	The
O	1504	1509	study
O	1510	1518	findings
O	1519	1531	demonstrated
O	1532	1536	that
O	1537	1540	the
O	1541	1544	use
O	1545	1547	of
O	1548	1559	antiseptics
O	1560	1562	at
O	1563	1566	the
O	1567	1572	drain
O	1573	1577	exit
O	1578	1582	site
O	1583	1596	significantly
O	1597	1604	reduced
O	1605	1614	bacterial
O	1615	1627	colonization
O	1628	1630	of
O	1631	1634	the
O	1635	1641	closed
O	1642	1650	drainage
O	1651	1657	system
O	1658	1660	in
O	1661	1667	breast
O	1668	1674	cancer
O	1675	1682	surgery
O	1682	1683	.

O	1684	1688	Semi
O	1688	1689	-
O	1689	1698	permeable
O	1699	1708	occlusive
O	1709	1722	chlorhexidine
O	1722	1723	-
O	1723	1734	impregnated
O	1735	1744	dressings
O	1745	1752	provide
O	1753	1755	an
O	1756	1767	opportunity
O	1768	1770	to
O	1771	1775	test
O	1776	1782	simple
O	1782	1783	,
O	1784	1788	safe
O	1788	1789	,
O	1790	1793	and
O	1794	1797	low
O	1797	1798	-
O	1798	1802	cost
O	1803	1816	interventions
O	1817	1821	that
O	1822	1825	may
O	1826	1832	reduce
O	1833	1838	drain
O	1839	1848	bacterial
O	1849	1861	colonization
O	1862	1865	and
O	1866	1869	SSI
O	1870	1875	after
O	1876	1882	breast
O	1883	1890	surgery
O	1890	1891	.
